NuProbe is a cutting-edge genomics and molecular diagnostics company.
NuProbe has raised $50.0M in total funding. The most recent round was Series B. The last funding was announced in June 2022.
NuProbe's investors include HSG, Pan-Lin Capital, Pappas Capital, Yonghua Capital, WuXi AppTec.
NuProbe is headquartered in Boston, United States.
NuProbe is a cutting-edge genomics and molecular diagnostics company.
NuProbe is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NuProbe — Funding & Investors." VCBacked, June 2, 2022, https://www.vcbacked.co/company/nuprobe. Accessed August 14, 2026.
VCBacked. (2022). NuProbe — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/nuprobe
{{cite web |title=NuProbe — Funding & Investors |url=https://www.vcbacked.co/company/nuprobe |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated